Reviewed,
UniProtKB/Swiss-Prot Q8TDN4 (CABL1_HUMAN)
Last modified
June 16, 2009.
Version 67.
History...
Clusters with 100%,
90%,
50% identity |
Documents (3) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: CDK5 and ABL1 enzyme substrate 1 Alternative name(s): Interactor with CDK3 1 Short name=Ik3-1 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 633 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is not processed. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | Cyclin-dependent kinase binding protein. Enhances cyclin-dependent kinase tyrosine phosphorylation by nonreceptor tyrosine kinases, such as that of CDK5 by activated ABL1, which leads to increased CDK5 activity and is critical for neuronal development, and that of CDK2 by WEE1, which leads to decreased CDK2 activity and growth inhibition. Positively affects neuronal outgrowth. Plays a role as a regulator for p53/p73-induced cell death By similarity. |
| Subunit structure | Found in a complex with p53/TP53. Found in a number of complexes with CDK2, CDK3, CDK5, ABL1, TDRD7, PCTK2, CCNA1, CCNE1 and TP73. Interacts with CDK2, CDK3, CDK5, ABL1 and TDRD7 By similarity. |
| Subcellular location | Nucleus By similarity. Cytoplasm By similarity. Note: Located in the cell body and proximal region of the developing axonal shaft of immature neurons. Located in axonal growth cone, but not in the distal part of the axon shaft or in dendritic growth cone of mature neurons By similarity. |
| Tissue specificity | Expressed in breast, pancreas, colon, head and neck (at protein level). Strongly decreased in more than half of cases of atypical endometrial hyperplasia and in more than 90% of endometrial cancers. Ref.4 Ref.6 |
| Developmental stage | Expression in the endometrial epithelium fluctuates during the menstrual cycle, being greater during the secretory phase when compared with the proliferative phase. Ref.6 |
| Induction | Up-regulated by progesterone and down-regulated by estrogen in benign endometrium. Ref.6 |
| Post-translational modification | Phosphorylated on Ser-313 by CCNE1/CDK3. Phosphorylated on serine/threonine residues by CDK5 and on tyrosine residues by ABL1. Also phosphorylated in vitro by CCNA1/CDK2, CCNE1/CDK2, CCNA1/CDK3 and CCNE1/CDK3 By similarity. |
| Involvement in disease | Defects in CABLES1 are associated with some colon and squamous cancers. |
| Sequence similarities | Belongs to the cyclin family. |
Ontologies
| Keywords | |
|---|---|
| Biological process | Cell cycle Cell division |
| Cellular component | Cytoplasm Nucleus |
| Coding sequence diversity | Alternative splicing |
| Molecular function | Cyclin |
| PTM | Phosphoprotein |
| Gene Ontology (GO) | |
| Biological process | cell cycle Inferred from electronic annotation. Source: UniProtKB-KW cell divisionInferred from electronic annotation. Source: UniProtKB-KW regulation of cell cycleInferred from electronic annotation. Source: InterPro regulation of cell divisionInferred from electronic annotation. Source: InterPro |
| Cellular component | cytosol Inferred from direct assay. Source: MGI nucleusInferred from electronic annotation. Source: UniProtKB-SubCell |
| Molecular function | cyclin-dependent protein kinase regulator activity Inferred from electronic annotation. Source: InterPro protein binding Ref.5Inferred from physical interaction. Source: IntAct |
| Complete GO annotation... | |
Alternative products
| This entry describes 3 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: Q8TDN4-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Note: No experimental confirmation available. | ||||||
| Isoform 2 (identifier: Q8TDN4-2) The sequence of this isoform differs from the canonical sequence as follows: 1-265: Missing. 266-282: PGQGGSTSAFEQLQRSR → MLSKRGCHARIYADFPI | ||||||
| Isoform 3 (identifier: Q8TDN4-3) The sequence of this isoform differs from the canonical sequence as follows: 1-497: Missing. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 633 | 633 | CDK5 and ABL1 enzyme substrate 1 | PRO_0000080510 | |||||
Regions | |||||||||
| Region | 1 – 109 | 109 | Interacts with TDRD7 By similarity | ||||||
| Region | 179 – 492 | 314 | Interacts with CDK3 By similarity | ||||||
| Compositional bias | 2 – 134 | 133 | Ala-rich | ||||||
Amino acid modifications | |||||||||
| Modified residue | 168 | 1 | Phosphoserine Ref.7 Ref.9 | ||||||
| Modified residue | 242 | 1 | Phosphoserine Ref.9 | ||||||
| Modified residue | 287 | 1 | Phosphoserine Ref.9 | ||||||
| Modified residue | 290 | 1 | Phosphoserine Ref.9 | ||||||
| Modified residue | 291 | 1 | Phosphoserine Ref.9 | ||||||
| Modified residue | 311 | 1 | Phosphoserine Ref.9 | ||||||
| Modified residue | 313 | 1 | Phosphoserine; by CDK2 and CDK3 By similarity | ||||||
| Modified residue | 373 | 1 | Phosphoserine Ref.9 | ||||||
| Modified residue | 415 | 1 | Phosphothreonine Ref.9 Ref.8 | ||||||
| Modified residue | 418 | 1 | Phosphoserine Ref.9 | ||||||
| Modified residue | 434 | 1 | Phosphoserine Ref.9 | ||||||
Natural variations | |||||||||
| Alternative sequence | 1 – 497 | 497 | Missing in isoform 3. | VSP_012695 | |||||
| Alternative sequence | 1 – 265 | 265 | Missing in isoform 2. | VSP_012696 | |||||
| Alternative sequence | 266 – 282 | 17 | PGQGG…LQRSR → MLSKRGCHARIYADFPI in isoform 2. | VSP_012697 | |||||
Experimental info | |||||||||
| Sequence conflict | 412 | 1 | R → W in AAL83906. Ref.4 | ||||||
Sequences
| ||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed: 14702039] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3). Tissue: Testis. |
| [2] | "DNA sequence and analysis of human chromosome 18." Nusbaum C., Zody M.C., Borowsky M.L., Kamal M., Kodira C.D., Taylor T.D., Whittaker C.A., Chang J.L., Cuomo C.A., Dewar K., FitzGerald M.G., Yang X., Abouelleil A., Allen N.R., Anderson S., Bloom T., Bugalter B., Butler J. Lander E.S.Nature 437:551-555(2005) [PubMed: 16177791] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [3] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). Tissue: Brain and Lung. |
| [4] | "Cables enhances cdk2 tyrosine 15 phosphorylation by Wee1, inhibits cell growth, and is lost in many human colon and squamous cancers." Wu C.-L., Kirley S.D., Xiao H., Chuang Y., Chung D.C., Zukerberg L.R. Cancer Res. 61:7325-7332(2001) [PubMed: 11585773] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 201-633 (ISOFORM 1), TISSUE SPECIFICITY, SUBCELLULAR LOCATION, INVOLVEMENT IN CANCER. Tissue: Brain. |
| [5] | "Differential effect of ik3-1/cables on p53- and p73-induced cell death." Tsuji K., Mizumoto K., Yamochi T., Nishimoto I., Matsuoka M. J. Biol. Chem. 277:2951-2957(2002) [PubMed: 11706030] [Abstract] Cited for: SUBCELLULAR LOCATION, IDENTIFICATION IN A COMPLEX WITH TP53. |
| [6] | "Loss of cables, a cyclin-dependent kinase regulatory protein, is associated with the development of endometrial hyperplasia and endometrial cancer." Zukerberg L.R., DeBernardo R.L., Kirley S.D., D'Apuzzo M., Lynch M.P., Littell R.D., Duska L.R., Boring L., Rueda B.R. Cancer Res. 64:202-208(2004) [PubMed: 14729625] [Abstract] Cited for: DEVELOPMENTAL STAGE, TISSUE SPECIFICITY, INDUCTION. |
| [7] | "A probability-based approach for high-throughput protein phosphorylation analysis and site localization." Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P. Nat. Biotechnol. 24:1285-1292(2006) [PubMed: 16964243] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-168, MASS SPECTROMETRY. Tissue: Epithelium. |
| [8] | "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis." Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III J. Proteome Res. 7:1346-1351(2008) [PubMed: 18220336] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-415, MASS SPECTROMETRY. |
| [9] | "Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle." Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R., Greff Z., Keri G., Stemmann O., Mann M. Mol. Cell 31:438-448(2008) [PubMed: 18691976] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-168; SER-242; SER-287; SER-290; SER-291; SER-311; SER-313; SER-373; THR-415; SER-418 AND SER-434, MASS SPECTROMETRY. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| AK093243 mRNA. Translation: BAC04107.1. AC105247 Genomic DNA. No translation available. AC011731 Genomic DNA. No translation available. BC004124 mRNA. Translation: AAH04124.2. BC037218 mRNA. Translation: AAH37218.1. AF348525 mRNA. Translation: AAL83906.1. | |
| IPI | IPI00178886. IPI00291427. IPI00549691. |
| RefSeq | NP_001094089.1. NP_612384.1. |
| UniGene | Hs.11108 |
3D structure databases | |
| ModBase | Search... |
Protein-protein interaction databases | |
| IntAct | Q8TDN4. 2 interactions. |
PTM databases | |
| PhosphoSite | Q8TDN4. |
Proteomic databases | |
| PRIDE | Q8TDN4. |
Genome annotation databases | |
| Ensembl | ENSG00000134508. Homo sapiens. [Contig view] |
| GeneID | 91768. |
| KEGG | hsa:91768. |
Organism-specific databases | |
| GeneCards | GC18P018970. |
| H-InvDB | HIX0014363. |
| HGNC | HGNC:25097. CABLES1. |
| MIM | 609194. gene. |
| PharmGKB | PA134880184. |
| GenAtlas | Search... |
Phylogenomic databases | |
| HOGENOM | Q8TDN4. |
| HOVERGEN | Q8TDN4. |
| OMA | Q8TDN4. MDPRRRQ. |
Gene expression databases | |
| ArrayExpress | Q8TDN4. |
| Bgee | Q8TDN4. |
| CleanEx | HS_CABLES1. |
| GermOnline | ENSG00000134508. Homo sapiens. |
Family and domain databases | |
| InterPro | IPR012388. Cables. IPR006670. Cyclin. [Graphical view] |
| PIRSF | PIRSF025798. Cables. 1 hit. |
| SMART | SM00385. CYCLIN. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other Resources | |
| NextBio | 77447. |
| SOURCE | Search... |
Entry information
| Entry name | CABL1_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q8TDN4 Secondary accession number(s): Q8N3Y8, Q8NA22, Q9BTG1 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | HPI (Human Proteome Initiative) | ||||||||
Relevant documents
| Human chromosome 18 Human chromosome 18: entries, gene names and cross-references to MIM |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with


